Researchers Upgrade Proton Therapy Beam Model Using Advanced GPU-Based Monte Carlo Simulation
Scientists at MD Anderson Cancer Center improved their independent dose calculation engine for the Hitachi PROBEAT proton therapy system by implementing double-Gaussian distributions for particle spatial and angular distributions. The upgrade aims to enhance both clinical quality assurance verification and research flexibility. More accurate dose modeling could improve treatment planning and enable faster implementation of new clinical techniques in proton therapy.
Researchers led by Qianxia Wang and colleagues at MD Anderson Cancer Center have enhanced their in-house dose engine—a GPU-based Fast Monte Carlo simulation tool independent of commercial treatment planning systems. The key improvement involves using double-Gaussian distributions to more accurately model both the spatial distribution and opening angle distribution of proton particles in the Hitachi PROBEAT system. This upgraded beam model is expected to generate more precise phase space files, which serve as the foundation for dose calculations. The independent dose engine serves dual purposes: it provides a reliable tool for patient quality assurance verification separate from the clinical treatment planning system, and it offers the flexibility needed for cutting-edge research to implement new functions and techniques. The researchers anticipate these improvements will benefit both routine clinical operations and advanced research initiatives at the expanded MD Anderson proton center.
What different sources said
- arXiv physicsCenter
Beam modelling of Hitachi PROBEAT proton therapy system for a GPU-based Fast Monte Carlo dose engine
Related
Topology-Aware Thermodynamics Improves DNA Probe Specificity Design
Researchers developed a new framework for designing DNA probes that accounts for the spatial organization of matched sequences, not just overall thermodynamic stability. Traditional methods rely on scalar measures like melting temperature and free energy, which miss how mismatches are distributed along the probe. The approach could improve diagnostic accuracy in applications like HPV detection and gene expression profiling.
Study Identifies Optimal Thermal Dose for Combining Focused Ultrasound with Immunotherapy in Tumors
Researchers used multimodal PET imaging to identify an optimal thermal dose range for focused ultrasound ablation that destroys tumor tissue while preserving conditions for immunotherapy delivery. The study found that excessive heating collapses blood vessels needed for antibody access, while insufficient heating fails to adequately reduce tumor burden. The findings could guide clinical design of combination treatments pairing thermal ablation with immunotherapies.
Plant MSH1 Protein Functions as Mismatch-Directed Nuclease for Organelle Genome Maintenance
Researchers have identified the precise mechanism by which the AtMSH1 protein in Arabidopsis plants recognizes and cleaves DNA mismatches and lesions, preventing mutations in organellar genomes. The protein combines a DNA mismatch recognition module with a nuclease domain that makes staggered cuts at specific positions relative to DNA damage. This discovery explains how plants maintain unusually low mutation rates in their mitochondrial and chloroplast DNA compared to other eukaryotes.